Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$14.2 - $18.63 $3,109 - $4,079
219 New
219 $3,000
Q2 2022

Jul 19, 2022

SELL
$13.01 - $27.22 $7,337 - $15,352
-564 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$16.79 - $27.09 $2,098 - $3,386
125 Added 28.47%
564 $13,000
Q3 2021

Oct 29, 2021

BUY
$15.78 - $24.77 $6,927 - $10,874
439 New
439 $7,000
Q2 2021

Aug 02, 2021

SELL
$19.4 - $27.42 $4,578 - $6,471
-236 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$25.02 - $54.99 $2,151 - $4,729
86 Added 57.33%
236 $6,000
Q3 2020

Oct 20, 2020

SELL
$36.42 - $57.0 $3,642 - $5,700
-100 Reduced 40.0%
150 $6,000
Q1 2020

Apr 14, 2020

BUY
$31.65 - $46.87 $1,582 - $2,343
50 Added 25.0%
250 $11,000
Q4 2019

Jan 27, 2020

SELL
$36.21 - $51.4 $3,621 - $5,140
-100 Reduced 33.33%
200 $9,000
Q3 2019

Oct 17, 2019

SELL
$22.22 - $44.01 $6,666 - $13,203
-300 Reduced 50.0%
300 $11,000
Q4 2018

Jan 17, 2019

SELL
$14.32 - $22.92 $2,964 - $4,744
-207 Reduced 25.65%
600 $10,000
Q3 2018

Nov 02, 2018

SELL
$13.03 - $21.81 $2,788 - $4,667
-214 Reduced 20.96%
807 $17,000
Q2 2018

Jul 27, 2018

SELL
$15.07 - $22.34 $7,218 - $10,700
-479 Reduced 31.93%
1,021 $16,000
Q1 2018

Apr 30, 2018

SELL
$22.47 - $32.33 $5,617 - $8,082
-250 Reduced 14.29%
1,500 $34,000
Q4 2017

Feb 01, 2018

BUY
$26.84 - $39.14 $4,026 - $5,871
150 Added 9.38%
1,750 $53,000
Q3 2017

Oct 24, 2017

SELL
$29.49 - $38.37 $2,949 - $3,836
-100 Reduced 5.88%
1,600 $60,000
Q2 2017

Aug 10, 2017

BUY
N/A
1,700
1,700 $47,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.79B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.